Aurinia Pharmaceuticals Inc.
18
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
22.2%
4 terminated/withdrawn out of 18 trials
77.8%
-8.7% vs industry average
44%
8 trials in Phase 3/4
64%
9 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis
Role: lead
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis
Role: lead
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
Role: lead
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients
Role: collaborator
Aurinia Renal Response in Active Lupus With Voclosporin
Role: lead
Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis
Role: lead
Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin
Role: lead
Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin
Role: lead
Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome
Role: lead
Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis
Role: lead
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
Role: lead
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
Role: lead
Aurinia Early Urinary Protein Reduction Predicts Response
Role: lead
Voclosporin in Healthy Japanese Volunteers
Role: lead
Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation
Role: lead
Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
Role: lead
Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients
Role: lead
A 36-Week Extension to Protocol ISA04-03
Role: lead
All 18 trials loaded